Susan E. Dorman - Concepedia

Author

Susan E. Dorman

Also Known As

Coetzee, Gerrit, Dorman, Susan E, F Maruri, Park, Jeong-Gun, Payam Nahid, S Dorman, S E Dorman, S. Dorman, S. E. Dorman, S.E. Dorman

213

Publications

12.9K

Citations

H-Index

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine Centers for Disease Control and Prevention National Institutes of Health Medical University of South Carolina

About

Susan E. Dorman is an author at Johns Hopkins University specializing in medicine, tuberculosis, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	25	29	4.6K
2	Health Sciences	6	6	2K
3	Engineering	3	3	111
4	Public Health	2	2	76
5	Biochemistry	1	1	24

Susan E. Dorman

110

Publications

10.4K

Citations

H-Index

Page 1

	Year	Citations
Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Payam Nahid, Susan E. Dorman, Narges Alipanah, Clinical Infectious Diseases Tuberculosis TreatmentTuberculosis PreventionPediatric Lung DiseasePrevention/infectious Diseases SocietyDiagnostics	2016	1.4K
Xpert MTB/RIF Ultra for detection of Mycobacterium tuberculosis and rifampicin resistance: a prospective multicentre diagnostic accuracy study Susan E. Dorman, Samuel G. Schumacher, David Alland, The Lancet Infectious Diseases	2017	666
Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis Susan E. Dorman, Payam Nahid, Ekaterina V. Kurbatova, New England Journal of Medicine	2021	521
A human IFNGR1 small deletion hotspot associated with dominant susceptibility to mycobacterial infection Emmanuelle Jouanguy, Salma Lamhamedi‐Cherradi, David A. Lammas, Nature Genetics Medical MicrobiologyMicrobial DiseasePathogenesisImmunologyPathogen Characterization	1999	486
Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection. Susan E. Dorman, Steven M. Holland Journal of Clinical Investigation Disseminated Mycobacterium FortuitumMicrobial PathogensImmunodeficienciesImmunologyPathology	1998	423
Clinical features of dominant and recessive interferon γ receptor 1 deficiencies Susan E. Dorman, Capucine Pïcard, David A. Lammas, The Lancet Primary ImmunodeficiencyAutoimmune DiseaseGenetic DisorderImmunodeficienciesGenetics	2004	408
Executive Summary: Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis Payam Nahid, Susan E. Dorman, Narges Alipanah, Clinical Infectious Diseases	2016	310
Genomic analysis of globally diverse Mycobacterium tuberculosis strains provides insights into the emergence and spread of multidrug resistance Abigail L. Manson, Keira A. Cohen, Thomas Abeel, Nature Genetics Medical MicrobiologyPulmonary TuberculosisAntimicrobial Resistance GeneHealth SciencesGenomic Analysis	2017	287
Substitution of Moxifloxacin for Isoniazid during Intensive Phase Treatment of Pulmonary Tuberculosis Susan E. Dorman, John L. Johnson, Stefan Goldberg, American Journal of Respiratory and Critical Care Medicine	2009	265
Neutrophil-specific Granule Deficiency Results from a Novel Mutation with Loss of Function of the Transcription Factor CCAAT/Enhancer Binding Protein ε Julie Lekstrom-Himes, Susan E. Dorman, Piroska Kopar, The Journal of Experimental Medicine	1999	200

Page 1